151 related articles for article (PubMed ID: 19226203)
1. Infection after elective colorectal surgery: bacteriological analysis of failures in a randomized trial of cefotetan vs. ertapenem prophylaxis.
Goldstein EJ; Citron DM; Merriam CV; Abramson MA
Surg Infect (Larchmt); 2009 Apr; 10(2):111-8. PubMed ID: 19226203
[TBL] [Abstract][Full Text] [Related]
2. Effect of body mass index and ertapenem versus cefotetan prophylaxis on surgical site infection in elective colorectal surgery.
Itani KM; Jensen EH; Finn TS; Tomassini JE; Abramson MA
Surg Infect (Larchmt); 2008 Apr; 9(2):131-7. PubMed ID: 18426345
[TBL] [Abstract][Full Text] [Related]
3. Comparative costs of ertapenem and cefotetan as prophylaxis for elective colorectal surgery.
Wilson SE; Turpin RS; Kumar RN; Itani KM; Jensen EH; Pellissier JM; Abramson MA
Surg Infect (Larchmt); 2008 Jun; 9(3):349-56. PubMed ID: 18570576
[TBL] [Abstract][Full Text] [Related]
4. Ertapenem versus cefotetan prophylaxis in elective colorectal surgery.
Itani KM; Wilson SE; Awad SS; Jensen EH; Finn TS; Abramson MA
N Engl J Med; 2006 Dec; 355(25):2640-51. PubMed ID: 17182989
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of ertapenem: review of recent studies.
Wexler HM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
[TBL] [Abstract][Full Text] [Related]
6. Serum bactericidal activity against aerobes and anaerobes of volunteers receiving cefoxitin or cefotetan.
Cruciani M; Navarra A; Bono L; Concia E
Chemioterapia; 1988 Aug; 7(4):261-3. PubMed ID: 3180306
[TBL] [Abstract][Full Text] [Related]
7. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents.
Citron DM; Goldstein EJ; Merriam CV; Lipsky BA; Abramson MA
J Clin Microbiol; 2007 Sep; 45(9):2819-28. PubMed ID: 17609322
[TBL] [Abstract][Full Text] [Related]
8. Polyethylene glycol versus sodium phosphate mechanical bowel preparation in elective colorectal surgery.
Itani KM; Wilson SE; Awad SS; Jensen EH; Finn TS; Abramson MA
Am J Surg; 2007 Feb; 193(2):190-4. PubMed ID: 17236845
[TBL] [Abstract][Full Text] [Related]
9. Double-blind comparison of single-dose alatrofloxacin and cefotetan as prophylaxis of infection following elective colorectal surgery. Trovafloxacin Surgical Group.
Milsom JW; Smith DL; Corman ML; Howerton RA; Yellin AE; Luke DR
Am J Surg; 1998 Dec; 176(6A Suppl):46S-52S. PubMed ID: 9935257
[TBL] [Abstract][Full Text] [Related]
10. A multicenter study to compare cefotetan alone with cefotetan and metronidazole as prophylaxis against infection in elective colorectal operations.
Morton AL; Taylor EW; Lindsay G; Wells GR
Surg Gynecol Obstet; 1989 Jul; 169(1):41-5. PubMed ID: 2662452
[TBL] [Abstract][Full Text] [Related]
11. Single-dose amoxycillin-clavulanic acid vs. cefotetan for prophylaxis in elective colorectal surgery: a multicentre, prospective, randomized study. The PRODIGE Group.
Arnaud JP; Bellissant E; Boissel P; Carlet J; Chastang C; Lafaix C; Rio Y; Berganeschi R
J Hosp Infect; 1992 Nov; 22 Suppl A():23-32. PubMed ID: 1362746
[TBL] [Abstract][Full Text] [Related]
12. Lack of predictability of cefotetan in vitro susceptibility tests against cefotetan-resistant anaerobic bacteria in determining clinical and bacteriologic efficacies.
Sheikh W; Bobey DG
Diagn Microbiol Infect Dis; 1992; 15(7):595-600. PubMed ID: 1424516
[TBL] [Abstract][Full Text] [Related]
13. Carbapenems for surgical prophylaxis?
Sexton DJ
N Engl J Med; 2006 Dec; 355(25):2693-5. PubMed ID: 17182996
[No Abstract] [Full Text] [Related]
14. Prospective comparative study of cefotetan with piperacillin for prophylaxis against infection in elective colorectal surgery.
Hershman MJ; Swift RI; Reilly DT; Logan WA; Sackier JM; Gompertz H; Horner J; Baker NW; Wood CB
J R Coll Surg Edinb; 1990 Feb; 35(1):29-32. PubMed ID: 2342006
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection.
Pelak BA; Citron DM; Motyl M; Goldstein EJ; Woods GL; Teppler H
J Antimicrob Chemother; 2002 Nov; 50(5):735-41. PubMed ID: 12407133
[TBL] [Abstract][Full Text] [Related]
16. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic modelling of intravenous antibiotic prophylaxis in elective colorectal surgery.
Moine P; Fish DN
Int J Antimicrob Agents; 2013 Feb; 41(2):167-73. PubMed ID: 23182539
[TBL] [Abstract][Full Text] [Related]
19. Serum bactericidal activity against aerobes and anaerobes of volunteers receiving cefoxitin or cefotetan.
Cruciani M; Navarra A; Bono L; Concia E
J Chemother; 1989 Jul; 1(4 Suppl):101-2. PubMed ID: 16312323
[No Abstract] [Full Text] [Related]
20. Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
Tellado J; Woods GL; Gesser R; McCarroll K; Teppler H
Surg Infect (Larchmt); 2002; 3(4):303-14. PubMed ID: 12697078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
